DCF — COX MEDICAL CENTER BRANSON
Enterprise Value: $-65.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-65.0M
Enterprise Value
$-26.7M
PV of Cash Flows
$-38.3M
PV of Terminal Value
$-61.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $223.9M | $-0.7M | -0.0% | $-10.2M | $-9.2M |
| Year 2 | $230.6M | $1.6M | 1.0% | $-8.2M | $-6.7M |
| Year 3 | $237.5M | $4.0M | 2.0% | $-6.0M | $-4.5M |
| Year 4 | $244.6M | $5.4M | 2.0% | $-5.0M | $-3.4M |
| Year 5 | $252.0M | $6.2M | 2.0% | $-4.5M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-65.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$217.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00806838465340565
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5